Your browser doesn't support javascript.
loading
Tratar intensivamente con estatinas en prevención secundaria tiene ventajase inconvenientes / No disponible
Montero Balosa, M. C; Domínguez Camacho, J. C; Ortíz Rodríguez, O.
Affiliation
  • Montero Balosa, M. C; Servicio Andaluz de Salud. s. c. s. p
  • Domínguez Camacho, J. C; Servicio Andaluz de Salud. s. c. s. p
  • Ortíz Rodríguez, O; Servicio Extremeño de Salud. s. c. s. p
Fam. aten. prim ; 9(3): 100-102, dic. 2011. tab
Article in Spanish | IBECS | ID: ibc-106491
Responsible library: ES1.1
Localization: BNCS
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors Type of study: Etiology study / Risk factors Limits: Humans Language: Spanish Journal: Fam. aten. prim Year: 2011 Document type: Article Institution/Affiliation country: Servicio Andaluz de Salud/s. p / Servicio Extremeño de Salud/s. p
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: IBECS Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors Type of study: Etiology study / Risk factors Limits: Humans Language: Spanish Journal: Fam. aten. prim Year: 2011 Document type: Article Institution/Affiliation country: Servicio Andaluz de Salud/s. p / Servicio Extremeño de Salud/s. p
...